Evidence map›Paper›PMID 38206043›Full record

ArticleAntimicrobial agents and chemotherapy2024

Novel resistance ICEs carrying the

Alberto Antonelli, Marco Coppi, Chiara Bonaiuto, Nicla Giovacchini, Guendalina Vaggelli, Alberto Farese, Simona Pollini, Gian Maria Rossolini

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Molecular Epidemiology ofAntibiotics (Basel, Switzerland) · 2024
    Review
  3. Antimicrobial agents and chemotherapy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alberto Antonelli *Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID 0000-0003-0295-6877
Marco Coppi *Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Chiara BonaiutoDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Nicla GiovacchiniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Guendalina VaggelliMicrobiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
Alberto FareseInfectious and Tropical Diseases Unit, Florence Careggi University Hospital, Florence, Italy.
Simona PolliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Gian Maria RossoliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID 0000-0002-9386-0434
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR) PAN-HUB 2021Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR) PRIN 2022 grant prot. 2022WBPFSC
6 · The paper itself

Abstract

FIM-1 is an acquired metallo-β-lactamase identified in a multidrug-resistant

Indexed as

beta-LactamasesPseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsHumansAnti-Bacterial Agentsbeta-Lactamasescomparative genomicsFIM-1integrative and conjugative elementmetallo-β-lactamasePseudomonas aeruginosa

Identifiers

PMID38206043
PMCPMC10848763
OpenAlexW4390743758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.